Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma

NCT06580054 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Interventions

PROCEDURE: Computed Tomography
OTHER: Digital Photography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Pembrolizumab

Sponsor

University of Michigan Rogel Cancer Center